Magnesium sulphate and cerebral vasospasm

Lancet Neurology

Volumn 4, Issue 6, 2005, Pages 329-330

  Manno, Edward M ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; MAGNESIUM SULFATE; NIMODIPINE;

BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; SIDE EFFECT;

EID: 19344362710     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(05)70080-6     Document Type: Letter

References (5)

1. WM van den Bergh Magnesium sulfate in aneurismal subarachnoid hemorrhage: a randomized controlled trial Stroke 36 2005 1 5
2. RL Macdonald, DJ Curry, Y Aihara, ZD Zhang, BS Jahromi, R Yassari Magnesium and experimental vasospasm J Neurosurg 100 2004 106 110
3. GJE Rinkel, VL Feigin, A Algra, WM van den Bergh, M Vermeulen, J van Gijn Calcium antagonists for aneurysmal subarachnoid hemorrhage Cochrane Database Syst Rev 2005 1 CD000277
4. Intravenous Magnesium Efficacy in Stroke (IMAGES) Investigators Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomized controlled trial Lancet 363 2004 439 445
5. JA McKee, RP Brewer, GE Macy Analysis of the brain bioavailability of peripherally administered magnesium sulphate: a study in humans with acute brain injury undergoing prolonged induced hypermagnesemia Crit Care Med 33 2005 661 666